Hutch News

Hutch News

Stories tagged 'biopsy'

Is metastatic prostate cancer tailor-made for precision oncology?

New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients

Feb. 29, 2016 | By Sabrina Richards / Fred Hutch News Service

A new study from scientists at Fred Hutchinson Cancer Research Center and the University of Washington suggests metastatic prostate cancer may present just the pair of characteristics needed for precision oncology: Metastases from different patients varied widely in their genetic characteristics, and metastases within a single patient were remarkably similar.

View story >

Change in PSA level may not predict prostate cancer

Center statistical analyses show screening for PSA velocity can lead to unnecessary biopsies

March 14, 2011

New research has shown that change in PSA levels over time—known as PSA velocity—is a poor predictor of prostate cancer and may lead to many unnecessary biopsies. The study findings were published online Feb. 24 in the Journal of the National Cancer Institute. Fred Hutchinson Cancer Research Center researcher, Cathee Till of the Public Health Sciences Division, conducted statistical analyses.

View story >

Targeted breast ultrasound can reduce biopsies for young women

SCCA finds noninvasive screening better for evaluating anomalies in women under 40

Dec. 14, 2009

Targeted breast ultrasound of suspicious areas of the breast is a safe, reliable and cost-effective alternative to invasive biopsies for women under age 40, according to two Seattle Cancer Care Alliance studies.

View story >

A preliminary model for predicting malignancy

New statistical model may improve the ability to distinguish between cancerous and non-cancerous breast lesions and reduce the need for biopsies

Dec. 1, 2008 | By Dean Forbes

Dr. Wendy DeMartini and colleagues in the breast-imaging department at the Seattle Cancer Care Alliance developed a preliminary statistical model that breast radiologists could use eventually when deciding whether a lesion found on breast MRI is likely to be malignant or benign.

View story >

Even short-term combined hormone therapy use presents risks

Study finds hormone therapy appears to increase frequency of abnormal mammograms, breast biopsies

Feb. 25, 2008

Fred Hutchinson Cancer Research Center's Dr. Anne McTiernan and colleagues from the Public Health Sciences Division and the Los Angeles Biomedical Research Institute at Harbor–UCLA Medical Center co-authored a study on the connection between combined hormone therapy use and breast-cancer detection.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.